How to manage Helicobacter pylori after sequential therapy failure?
Zullo
Angelo
A
Hassan
Cesare
C
Cristofari
Francesca
F
Iegri
Claudia
C
De Francesco
Vincenzo
V
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D016481:Helicobacter Infections / Q000382:microbiology / Q000628:therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D064747:Lansoprazole; D015242:Ofloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D064750:Rabeprazole; D017211:Treatment Failure; D016896:Treatment Outcome
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D064747:Lansoprazole; D064750:Rabeprazole; D000658:Amoxicillin; D015242:Ofloxacin